MUSC partners with Revival Healthcare Capital

The Medical University of South Carolina has entered a partnership with Revival Healthcare Capital, an investment firm focused on medical devices.

The partnership is intended to accelerate evaluation, development and clinic advancement of medical technologies. A news release said the organizations have a five-year agreement with a plan to quickly begin project-specific initiatives.

“This collaboration reflects MUSC’s commitment to advancing innovation that improves patient care and health outcomes,” Dr. David Cole, president of MUSC, said in the release. “By working closely with Revival Healthcare Capital, our clinicians and researchers can help evaluate and inform the development of promising medical technologies, strengthening the pathway from clinical insight to real world impact.”

Clinicians and experts at MUSC will be invited to provide clinical and procedural insights to evaluate the technology with Revival’s investment plan. Additionally, some MUSC leaders will be advisers to the investment firm’s portfolio companies, according to the release.

The partnership put MUSC-originated devices on a quicker pathway to evaluation, with investment to support later clinical development.

“We are pleased to partner with MUSC to create a repeatable, high-velocity collaboration model that supports our investment strategy and our portfolio companies,” Todd Pope, senior partner at Revival Healthcare Capital, said in the release. “By combining Revival’s flexible capital model and operational capabilities with MUSC’s strong collaboration across patient care, research and education, we believe this partnership can advance technologies that address unmet patient needs.”